A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation
Open Access
- 1 January 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 30 (1) , 206-214
Abstract
Background: Acute intervertebral disk herniation (IVDH) is a common cause of spinal cord injury in dogs and currently there is no proven medical treatment to counter secondary injury effects. Use of methylprednisolone sodium succinate (MPSS) or polyethylene glycol (PEG) as neuroprotectants is advocated but controversial because neither treatment has been tested in placebo-controlled, randomized, blinded trials in dogs. Hypothesis: Polyethylene glycol will improve the outcome of severe spinal cord injury caused by IVDH compared to MPSS or placebo. Animals: Client-owned dogs with acute onset of thoracolumbar IVDH causing paralysis and loss of nociception for <24 hours. Methods: Dogs were randomized to receive MPSS, PEG, or placebo; drugs appeared identical and group allocation was masked. Drug administration was initiated once the diagnosis of IVDH was confirmed and all dogs underwent hemilaminectomy. Neurologic function was assessed 2, 4, 8, and 12 weeks postoperatively using an open field gait score (OFS) as the primary outcome measure. Outcomes were compared by the Wilcoxon rank sum test. Results: Sixty-three dogs were recruited and 47.6% recovered ambulation. 17.5% developed progressive myelomalacia but there was no association with group. There was no difference in OFS among groups. Although full study power was not reached, conditional power analyses indicated the futility of continued case recruitment. Conclusions: This clinical trial did not show a benefit of either MPSS or PEG in the treatment of acute, severe thoracolumbar IVDH when used as adjunctive medical treatment administered to dogs presenting within 24 hours of onset of paralysis.Keywords
Funding Information
- Morris Animal Foundation (D07CA‐064)
This publication has 46 references indexed in Scilit:
- Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury — How much is enough?Experimental Neurology, 2013
- A Systematic Review of Non-Invasive Pharmacologic Neuroprotective Treatments for Acute Spinal Cord InjuryJournal of Neurotrauma, 2011
- Magnesium Chloride in a Polyethylene Glycol Formulation as a Neuroprotective Therapy for Acute Spinal Cord Injury: Preclinical Refinement and OptimizationJournal of Neurotrauma, 2009
- Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injuryNeurosurgical Focus, 2008
- A review of methods for futility stopping based on conditional powerStatistics in Medicine, 2005
- Complications of Methylprednisolone Sodium Succinate Therapy in Dachshunds with Surgically Treated Intervertebral Disc DiseaseJournal of Veterinary Emergency and Critical Care, 2001
- Clinicopathologic Effects of a 21‐Aminosteroid Compound (U74389G) and High‐Dose Methylprednisolone on Spinal Cord Function After Simulated Spinal Cord TraumaVeterinary Surgery, 1995
- Determining the Appropriate Sample Size for Nonparametric Tests for Location ShiftTechnometrics, 1991
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990
- Decompressive laminectomy in thoraco‐lumbar disc protrusion with paraplegia in the dogJournal of Small Animal Practice, 1970